Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

SZSE:002675.SZ

17.35 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q1
Revenue 686.928706.505741.721773.482647.229690.304800.333934.51850.5841.514976.379885.326879.7361,116.597969.532935.707890.215841.911931.027932.51713.529817.866848.326792.536534.033702.237680.309550.773399.504467.722423.674387.975316.23383.556289.376255.902229.617239.346177.827205.302172.441169.138177.188208.575196.12204.586173.787207.235189.123147.454136.602150.792152.906158.348175.495224.772298.959
Cost of Revenue 375.506338.982391.078422.689363.781353.255463.751541.945447.006464.336525.963515.418544.965698.859524.501547.643538.874468.584404.547457.384388.265336.884349.418312.645217.575295.656274.469228.932196.773213.961178.335179.238153.896161.985171.968133.597144.966117.242120.16140.499115.374109.29114.434136.975141.877150.331136.17159.478147.477112.034100.51102.23498.719111.144134.468177.592232.953
Gross Profit 311.422367.523350.643350.794283.448337.049336.582392.565403.494377.178450.416369.907334.771417.738445.03388.064351.342373.327526.48475.127325.265480.982498.908479.892316.458406.581405.84321.841202.731253.761245.34208.737162.335221.57117.408122.30484.652122.10457.66764.80357.06759.84862.75471.654.24454.25537.61747.75741.64535.4236.09248.55754.18747.20341.02747.17966.006
Gross Profit Ratio 0.4530.520.4730.4540.4380.4880.4210.420.4740.4480.4610.4180.3810.3740.4590.4150.3950.4430.5650.510.4560.5880.5880.6060.5930.5790.5970.5840.5070.5430.5790.5380.5130.5780.4060.4780.3690.510.3240.3160.3310.3540.3540.3430.2770.2650.2160.230.220.240.2640.3220.3540.2980.2340.210.221
Reseach & Development Expenses 44.008126.5862.96545.71445.20972.46140.8336.61147.32264.25631.67130.3137.28446.14232.34827.96331.10437.30920.99932.75718.32231.8920.16321.71714.9435.20530.75731.8557.95956.0439.36314.234042.177018.324038.144016.4037.431012.806015.35906.694030.2760000000
General & Administrative Expenses 89.592-130.393171.803-39.98174.807-117.638138.996-30.7577.57346.936132.663-22.77153.974-61.551112.397-21.86546.492-64.70842.138-35.27157.134-67.94342.187-22.07840.139-109.57365.438-24.51642.368-69.19133.659-19.97435.467-30.83224.234-17.69525.091-44.61521.034-13.70522.213-51.6523.69-9.02518.612-22.02312.357-7.23112.255-17.63410.0417.3668.9236.4227.29-2.966.19
Selling & Marketing Expenses 96.48920.277153.86498.194103.238101.409102.987138.096165.018156.307151.363132.804126.474121.553173.826142.66154.245156.378266.124178.206142.708238.718243.941211.041139.15201.163162.474126.65384.111107.41894.92377.41853.78994.49737.19939.15424.07147.38615.3279.7977.8198.7679.8179.3838.0666.284.3774.4982.645.7945.0363.2262.1123.2763.1682.9361.656
SG&A 186.081-110.115325.66758.214178.045-16.229241.983107.346242.591209.031284.026110.033180.44860.002286.223120.795200.73791.67308.263142.936199.843170.775286.128188.963179.28991.59227.912102.136126.47938.227128.58157.44589.25663.66561.43321.45949.1622.77136.361-3.90830.033-42.88333.5060.35826.678-15.74416.734-2.73314.895-11.8415.07610.59111.0369.69810.458-0.0247.846
Other Expenses 46.042334.628-95.985-0.378-0.02-23.409-0.362-0.092-1.838121.665-75.39682.4113.717140.638-65.3760.355-0.5973.057-0.2890.2-0.739-68.0980.488-12.844-0.403-16.7393.393-12.2370.143-10.0872.6472.890.117-3.8713.5584.290.4593.6041.8840.660.4472.3911.9210.707-0.0034.7737.7970.52815.2870.0752.3180.0020.0361.5460.832.011.627
Operating Expenses 276.132362.536292.647219.013226.398239.351201.108234.76288.075394.952240.301222.753221.448246.782253.194221.766234.418248.214332.743237.334220.7324.201312.33273.032198.61257.283232.204176.858129.779150.403133.961115.49892.674142.19663.84460.450.97584.18137.77231.59731.20631.69334.74535.04527.59330.4617.71816.81515.78316.69415.72511.38811.77810.44311.26611.7939.23
Operating Income 35.2914.987108.62873.81584.009-71.801135.432191.33486.697-17.774210.656169.60985.76-65.345171.428142.293108.556105.164185.39214.068104.523-67.94169.35184.925107.433128.325143.868119.35476.01970.659105.2180.0458.25977.19154.33365.07932.15841.04626.60532.5727.95329.82828.89937.49830.20822.33618.89128.30527.08819.80625.88935.6341.37434.6926.14631.05352.922
Operating Income Ratio 0.0510.0070.1460.0950.13-0.1040.1690.2050.102-0.0210.2160.1920.097-0.0590.1770.1520.1220.1250.1990.230.146-0.0830.20.2330.2010.1830.2110.2170.190.1510.2480.2060.1840.2010.1880.2540.140.1710.150.1590.1620.1760.1630.180.1540.1090.1090.1370.1430.1340.190.2360.2710.2190.1490.1380.177
Total Other Income Expenses Net -0.439-0.306-51.633-0.378-0.02-3.821-0.362-0.092-0.107-1.039-0.416-0.242-0.979-0.442-0.150.355-0.5973.057-0.2890.2-0.7391.7640.4880.141-0.403-1.613.3930.2570.143-3.6612.3492.4150.117-4.82213.6474.2010.4593.5881.8840.420.3752.5921.9190.69-0.0074.7627.7970.52716.509-0.2767.8400.0361.5460.832.011.627
Income Before Tax 34.8514.68156.99573.43783.989-75.622135.071191.24286.59-18.813210.241169.36784.781-65.787171.279142.648107.959108.221185.101214.269103.784-66.176169.837185.066107.03126.715147.261119.61176.16266.998107.55982.45658.37672.36967.9869.2832.61744.63428.48932.9928.32832.4230.81838.18730.20127.09926.68828.83242.37119.5328.20735.6341.40936.23626.97633.06454.549
Income Before Tax Ratio 0.0510.0070.0770.0950.13-0.110.1690.2050.102-0.0220.2150.1910.096-0.0590.1770.1520.1210.1290.1990.230.145-0.0810.20.2340.20.180.2160.2170.1910.1430.2540.2130.1850.1890.2350.2710.1420.1860.160.1610.1640.1920.1740.1830.1540.1320.1540.1390.2240.1320.2060.2360.2710.2290.1540.1470.182
Income Tax Expense 17.70214.91325.26719.4418.05810.85817.4431.09123.67511.1529.80533.20618.58820.8428.94526.00819.4565.80332.62538.78316.6915.27634.01334.76418.06519.06631.68218.59211.61510.06714.65814.80611.12714.9619.60711.4545.9098.175.5565.2813.8946.216.6535.9694.9294.9574.9173.6077.7283.1564.6115.6736.45.3034.2155.1658.203
Net Income 24.73216.95855.07847.46264.328-76.076101.505134.250.107-23.019161.571113.81854.922-86.628106.84488.06166.89879.56118.967145.3773.869-124.17100.714113.6564.5286.72481.74268.5643.434.37565.40441.61531.2433.50242.20838.48516.75821.15918.73226.04123.81325.39923.31330.85824.38920.45320.75824.95734.68116.41423.63929.97135.03530.91322.7827.89646.345
Net Income Ratio 0.0360.0240.0740.0610.099-0.110.1270.1440.059-0.0270.1650.1290.062-0.0780.110.0940.0750.0940.1280.1560.104-0.1520.1190.1430.1210.1230.120.1240.1090.0730.1540.1070.0990.0870.1460.150.0730.0880.1050.1270.1380.150.1320.1480.1240.10.1190.120.1830.1110.1730.1990.2290.1950.130.1240.155
EPS 0.030.0210.0670.0580.078-0.0920.120.160.061-0.0280.20.140.069-0.110.130.110.0830.0990.150.180.092-0.150.130.140.080.110.110.0980.0620.0490.0930.0590.0440.0510.0640.0580.0250.0410.0370.050.0460.0470.0430.060.0470.0390.040.0480.0670.0320.0470.0770.090.0790.0580.0720.12
EPS Diluted 0.030.0210.0670.0580.078-0.0920.120.160.061-0.0280.20.140.069-0.110.130.110.0830.0990.150.180.092-0.150.130.140.080.110.110.0980.0620.0490.0930.0590.0440.0510.0640.0580.0250.0410.0370.050.0460.0470.0430.060.0470.0390.040.0480.0670.0320.0470.0770.090.0790.0580.0720.12
EBITDA 62.59633.343102.914116.906143.25747.325197.732239.789135.902115.527239.582220.167103.951155.411212.637191.49154.596140.978218.563239.472142.17378.553188.893196.546121.119138.672182.175149.94787.01483.792114.2586.90669.66105.83453.56472.44734.71661.68419.89538.41825.8643.29228.00942.43926.6549.8620.45738.46327.35117.720.36837.1742.4137.24529.76135.38656.776
EBITDA Ratio 0.0910.0470.1390.1510.2210.0690.2470.2570.160.1370.2450.2490.1180.1390.2190.2050.1740.1670.2350.2570.1990.0960.2230.2480.2270.1970.2680.2720.2180.1790.270.2240.220.2760.1850.2830.1510.2580.1120.1870.150.2560.1580.2030.1360.2440.1180.1860.1450.120.1490.2460.2770.2350.170.1570.19